Methods: This retrospective, case series study included children diagnosed Alport syndrome based on discovery of genetic mutations in one of the COL4A3, COL4A4, and COL4A5 genes who were treated at Department of Nephrology and Endocrinology, Children Hospital 1 from January 2013 to March 2020.